176 related articles for article (PubMed ID: 19956622)
1. Functional characterization of antibodies against Neisseria gonorrhoeae opacity protein loops.
Cole JG; Jerse AE
PLoS One; 2009 Dec; 4(12):e8108. PubMed ID: 19956622
[TBL] [Abstract][Full Text] [Related]
2. In vivo selection for Neisseria gonorrhoeae opacity protein expression in the absence of human carcinoembryonic antigen cell adhesion molecules.
Simms AN; Jerse AE
Infect Immun; 2006 May; 74(5):2965-74. PubMed ID: 16622235
[TBL] [Abstract][Full Text] [Related]
3. Opacity proteins increase Neisseria gonorrhoeae fitness in the female genital tract due to a factor under ovarian control.
Cole JG; Fulcher NB; Jerse AE
Infect Immun; 2010 Apr; 78(4):1629-41. PubMed ID: 20100859
[TBL] [Abstract][Full Text] [Related]
4. Complement-Dependent Serum Bactericidal Assays for Neisseria gonorrhoeae.
Gulati S; Rice PA; Ram S
Methods Mol Biol; 2019; 1997():267-280. PubMed ID: 31119629
[TBL] [Abstract][Full Text] [Related]
5. Interactions of Neisseria gonorrhoeae with human neutrophils: studies with purified PII (Opa) outer membrane proteins and synthetic Opa peptides.
Naids FL; Belisle B; Lee N; Rest RF
Infect Immun; 1991 Dec; 59(12):4628-35. PubMed ID: 1718877
[TBL] [Abstract][Full Text] [Related]
6. Critical determinants of host receptor targeting by Neisseria meningitidis and Neisseria gonorrhoeae: identification of Opa adhesiotopes on the N-domain of CD66 molecules.
Virji M; Evans D; Hadfield A; Grunert F; Teixeira AM; Watt SM
Mol Microbiol; 1999 Nov; 34(3):538-51. PubMed ID: 10564495
[TBL] [Abstract][Full Text] [Related]
7. Sequence diversity, predicted two-dimensional protein structure, and epitope mapping of neisserial Opa proteins.
Malorny B; Morelli G; Kusecek B; Kolberg J; Achtman M
J Bacteriol; 1998 Mar; 180(5):1323-30. PubMed ID: 9495774
[TBL] [Abstract][Full Text] [Related]
8. Antibody to reduction modifiable protein increases the bacterial burden and the duration of gonococcal infection in a mouse model.
Gulati S; Mu X; Zheng B; Reed GW; Ram S; Rice PA
J Infect Dis; 2015 Jul; 212(2):311-5. PubMed ID: 25596304
[TBL] [Abstract][Full Text] [Related]
9. Topology of outer membrane porins in pathogenic Neisseria spp.
van der Ley P; Heckels JE; Virji M; Hoogerhout P; Poolman JT
Infect Immun; 1991 Sep; 59(9):2963-71. PubMed ID: 1652557
[TBL] [Abstract][Full Text] [Related]
10. Location of a blocking epitope on outer-membrane protein III of Neisseria gonorrhoeae by synthetic peptide analysis.
Virji M; Heckels JE
J Gen Microbiol; 1989 Jul; 135(7):1895-9. PubMed ID: 2482335
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum.
Rice PA; Vayo HE; Tam MR; Blake MS
J Exp Med; 1986 Nov; 164(5):1735-48. PubMed ID: 3095479
[TBL] [Abstract][Full Text] [Related]
12. Serum resistance of Neisseria gonorrhoeae. Does it thwart the inflammatory response and facilitate the transmission of infection?
Rice PA; McQuillen DP; Gulati S; Jani DB; Wetzler LM; Blake MS; Gotschlich EC
Ann N Y Acad Sci; 1994 Aug; 730():7-14. PubMed ID: 8080215
[TBL] [Abstract][Full Text] [Related]
13. Mapping the binding domains on meningococcal Opa proteins for CEACAM1 and CEA receptors.
de Jonge MI; Hamstra HJ; van Alphen L; Dankert J; van der Ley P
Mol Microbiol; 2003 Nov; 50(3):1005-15. PubMed ID: 14617157
[TBL] [Abstract][Full Text] [Related]
14. Gonococcal MtrE and its surface-expressed Loop 2 are immunogenic and elicit bactericidal antibodies.
Wang S; Xue J; Lu P; Ni C; Cheng H; Han R; van der Veen S
J Infect; 2018 Sep; 77(3):191-204. PubMed ID: 29902495
[TBL] [Abstract][Full Text] [Related]
15. Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae.
Humbert MV; Christodoulides M
Vaccine; 2018 Jun; 36(27):3926-3936. PubMed ID: 29803329
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to N-terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated.
Elkins C; Carbonetti NH; Varela VA; Stirewalt D; Klapper DG; Sparling PF
Mol Microbiol; 1992 Sep; 6(18):2617-28. PubMed ID: 1280317
[TBL] [Abstract][Full Text] [Related]
17. Antibodies with higher bactericidal activity induced by a Neisseria gonorrhoeae Rmp deletion mutant strain.
Li G; Xie R; Zhu X; Mao Y; Liu S; Jiao H; Yan H; Xiong K; Ji M
PLoS One; 2014; 9(3):e90525. PubMed ID: 24594737
[TBL] [Abstract][Full Text] [Related]
18. Conjugates of synthetic cyclic peptides elicit bactericidal antibodies against a conformational epitope on a class 1 outer membrane protein of Neisseria meningitidis.
Hoogerhout P; Donders EM; van Gaans-van den Brink JA; Kuipers B; Brugghe HF; van Unen LM; Timmermans HA; ten Hove GJ; de Jong AP; Peeters CC
Infect Immun; 1995 Sep; 63(9):3473-8. PubMed ID: 7543883
[TBL] [Abstract][Full Text] [Related]
19. The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.
Leduc I; Connolly KL; Begum A; Underwood K; Darnell S; Shafer WM; Balthazar JT; Macintyre AN; Sempowski GD; Duncan JA; Little MB; Rahman N; Garges EC; Jerse AE
PLoS Pathog; 2020 Dec; 16(12):e1008602. PubMed ID: 33290434
[TBL] [Abstract][Full Text] [Related]
20. Functional activity of antibodies against the recombinant OpaJ protein from Neisseria meningitidis.
de Jonge MI; Vidarsson G; van Dijken HH; Hoogerhout P; van Alphen L; Dankert J; van der Ley P
Infect Immun; 2003 May; 71(5):2331-40. PubMed ID: 12704102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
